In invasive triple-negative breast cancer cells, mutating the three HMGA1 serines (99, 102, and 103) phosphorylated by casein kinase 2 (CK2) results in decreased HMGA1 secretion and disrupts the invasive properties of the cell line [24]. This evidence concerns the gene HMGA1 and triple-negative breast carcinoma.